Skip to main content

Table 1 Characteristics of subjects (N = 11,212) with acute exacerbation of COPD by use of statin and/or ACE inhibitors versus non-users of either medication*

From: Impact of statins and ACE inhibitors on mortality after COPD exacerbations

Variables

Users of statins or ACE inhibitors

(N = 4711)

Non-users

(N = 6501)

P-value

Age (mean, SD)

73.5 (5.4)

74.3 (5.8)

<0.0001

Men

4616 (98)

6377 (98)

0.7

Race

   

   White

3829 (81)

5397 (83)

 

   Black

653 (45)

785 (54)

 

   Hispanic

124 (3)

176 (3)

0.04

Married

2219 (47)

2492 (39)

<0.0001

Charlson Comorbid Conditions

Myocardial infarction

956 (20)

568 (9)

<0.0001

Congestive heart failure

2565 (54)

2001 (30)

<0.0001

Peripheral vascular disease

881 (19)

880 (14)

<0.0001

Stroke

867 (18)

819 (13)

<0.0001

Peptic ulcer

368 (8)

493 (8)

0.7

Rheumatologic disease

125 (3)

158 (2)

0.5

Mild liver disease

40 (0.8)

82 (1)

0.04

Dementia

156 (3)

324 (5)

<0.0001

Diabetes

1678 (36)

1324 (20)

<0.0001

Diabetes with complications

488 (10)

258 (4)

<0.0001

Moderate Liver disease

19 (0.4)

36 (0.6)

0.3

Hemiplegia

72 (2)

70 (1)

0.04

Renal disease

480 (10)

393 (6)

<0.0001

Any malignancy

913 (19)

1373 (21)

0.02

Metastatic solid tumor

134 (3)

245 (4)

0.008

  1. *Data are presented as number (%) or mean (standard deviation)